Trial Profile
A Multicenter, Open Label, Efficacy and Safety Study of Parenteral SAR97276A in the Treatment of Symptomatic Uncomplicated and Severe Malaria in Adults and Children.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 20 May 2014
Price :
$35
*
At a glance
- Drugs SAR 97276 (Primary)
- Indications Malaria
- Focus Therapeutic Use
- Sponsors Sanofi
- 20 May 2014 New trial record